2019 | KML001, an arsenic compound, as salvage chemotherapy in refractory biliary tract cancers: A prospective study | HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL |
2020 | Lewis Antigen Phenotype and Survival of Patients With Pancreatic Cancer | PANCREAS |
2009 | Long-term follow up of gallbladder polyps | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
2021 | Long-term outcomes of fully covered self-expandable metal stents versus plastic stents in chronic pancreatitis
| SCIENTIFIC REPORTS |
2010 | Longer capsule endoscopy operation time increases the rate of complete examination of the small bowel | HEPATO-GASTROENTEROLOGY |
2023 | Machine-Learning Model for the Prediction of Hypoxaemia during Endoscopic Retrograde Cholangiopancreatography under Monitored Anaesthesia Care
| YONSEI MEDICAL JOURNAL |
2018 | Multicenter phase II trial of modified FOLFIRINOX in gemcitabine-refractory pancreatic cancer
| WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY |
2022 | Multifunctional microrobot with real-time visualization and magnetic resonance imaging for chemoembolization therapy of liver cancer
| SCIENCE ADVANCES |
2010 | Oct4 and Nanog expression is associated with early stages of pancreatic carcinogenesis | PANCREAS |
2018 | Oncologic outcomes after radical surgery for periampullary cancer in octogenarians
| Annals of Hepato-biliary-pancreatic Surgery |
2021 | Optimal drainage of anastomosis stricture after living donor liver transplantation | SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES |
2008 | Paclitaxel augments cytotoxic effect of photodynamic therapy using verteporfin in gastric and bile duct cancer cells | PHOTOCHEMICAL & PHOTOBIOLOGICAL SCIENCES |
2021 | Peripheral natural killer cell activity is associated with poor clinical outcomes in pancreatic ductal adenocarcinoma | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
2014 | Phase II clinical trial of ex vivo-expanded cytokine-induced killer cells therapy in advanced pancreatic cancer | CANCER IMMUNOLOGY IMMUNOTHERAPY |
2009 | Phase II study of 5-fluorouracil and paclitaxel in patients with gemcitabine-refractory pancreatic cancer | CANCER CHEMOTHERAPY AND PHARMACOLOGY |
2006 | Phase II Study of Cisplatin Combined with Weekly Gemcitabine in the Treatment of Patients with Metastatic Pancreatic Carcinoma | PANCREATOLOGY |
2006 | Phase II study of gemcitabine and cisplatin in advanced biliary tract cancer | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
2013 | Phase II Trial of Erlotinib Plus Gemcitabine Chemotherapy in Korean Patients with Advanced Pancreatic Cancer and Prognostic Factors for Chemotherapeutic Response
| GUT AND LIVER |
2009 | Phase II trial of S-1 and concurrent radiotherapy in patients with locally advanced pancreatic cancer | CANCER CHEMOTHERAPY AND PHARMACOLOGY |
2023 | Phenotypic characteristics of circulating tumor cells and predictive impact for efficacy of chemotherapy in patients with pancreatic cancer: a prospective study
| FRONTIERS IN ONCOLOGY |
2010 | Placement of a fully covered self-expandable metal stent in a young patient with chronic pancreatitis
| WORLD JOURNAL OF GASTROINTESTINAL ENDOSCOPY |
2019 | Plasma Chromogranin A as a Prognostic Marker in Pancreatic Ductal Adenocarcinoma | PANCREAS |
2023 | Plasmon-Enhanced Single Extracellular Vesicle Analysis for Cholangiocarcinoma Diagnosis
| ADVANCED SCIENCE |
2020 | Preoperative prediction of futile surgery in patients with radiologically resectable or borderline resectable pancreatic adenocarcinoma | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
2011 | Preoperative serum CA 19-9 level as a predictive factor for recurrence after curative resection in biliary tract cancer. | ANNALS OF SURGICAL ONCOLOGY |
2021 | Profiling of conditionally reprogrammed cell lines for in vitro chemotherapy response prediction of pancreatic cancer | EBIOMEDICINE |
2012 | Prognostic factors and characteristics of pancreatic neuroendocrine tumors: single center experience
| YONSEI MEDICAL JOURNAL |
2022 | Prognostic Factors in Patients Treated with Pembrolizumab as a Second-Line Treatment for Advanced Biliary Tract Cancer
| CANCERS |
2021 | Prognostic factors in patients with locally advanced or borderline resectable pancreatic ductal adenocarcinoma: chemotherapy vs. chemoradiotherapy | ABDOMINAL RADIOLOGY |
2009 | Prognostic value of thymidine phosphorylase expression for pancreatic cancer. | HEPATO-GASTROENTEROLOGY |
2011 | Prospective phase II trial of gemcitabine in combination with irinotecan as first-line chemotherapy in patients with advanced biliary tract cancer. | CHEMOTHERAPY |
2016 | Prospective Study for Comparison of Endoscopic Ultrasound-Guided Tissue Acquisition Using 25- and 22-Gauge Core Biopsy Needles in Solid Pancreatic Masses
| PLOS ONE |
2011 | Proteomic analysis of pancreatic juice for the identification of biomarkers of pancreatic cancer | JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY |
2020 | Radiographic portal or superior mesenteric vein invasion is an independent prognostic factor in non-metastatic pancreatic ductal adenocarcinoma: A missing block of clinical T staging? | PANCREATOLOGY |
2009 | Radiosensitization effect of STI-571 on pancreatic cancer cells in vitro | INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS |
2013 | Radiotherapy Prolongs Biliary Metal Stent Patency in Malignant Pancreatobiliary Obstructions
| GUT AND LIVER |
2024 | Randomized Trial of Prophylactic Antibiotics for Endoscopic Retrograde Cholangiopancreatography in Patients With Biliary Obstruction
| AMERICAN JOURNAL OF GASTROENTEROLOGY |
2014 | Recanalization of refractory benign biliary stricture using magnetic compression anastomosis | ENDOSCOPY |
2022 | Redundant Electromagnetic Control of an Endoscopic Magnetic Capsule Driven by Multiple Electromagnets Configuration | IEEE TRANSACTIONS ON INDUSTRIAL ELECTRONICS |
2022 | Regional lymph node metastasis detected on preoperative CT and/or FDG-PET may predict early recurrence of pancreatic adenocarcinoma after curative resection
| SCIENTIFIC REPORTS |
2023 | Response | GASTROINTESTINAL ENDOSCOPY |
2022 | Response to Neoadjuvant Therapy and Prognosis in Patients with Resectable Pancreatic Cancer: A Propensity Score Matching Analysis
| GUT AND LIVER |
2022 | Retrospective Evaluation of Treatment Response in Patients with Nonmetastatic Pancreatic Cancer Using CT and CA 19-9 | RADIOLOGY |
2018 | Revision of bilateral self-expandable metallic stents placed using the stent-in-stent technique for malignant hilar biliary obstruction | HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL |
2017 | Risk factors associated with adverse events during endoscopic ultrasound-guided tissue sampling
| PLOS ONE |
2016 | Risk Factors Associated with Loco-Regional Failure after Surgical Resection in Patients with Resectable Pancreatic Cancer.
| PLOS ONE |
2024 | Risk Stratification of Pancreatic Ductal Adenocarcinoma Patients Undergoing Curative-Intent Surgery after Neoadjuvant Therapy
| CANCER RESEARCH AND TREATMENT |
2022 | Safety and Efficacy of Allogeneic Natural Killer Cells in Combination with Pembrolizumab in Patients with Chemotherapy-Refractory Biliary Tract Cancer: A Multicenter Open-Label Phase 1/2a Trial
| CANCERS |
2018 | Safety and efficacy of early feeding based on clinical assessment at 4 hours after ERCP: a prospective randomized controlled trial | GASTROINTESTINAL ENDOSCOPY |
2009 | Self-expandable metal stents for recurrent malignant obstruction after gastric surgery | HEPATO-GASTROENTEROLOGY |
2021 | Serum Dickkopf-1 in Combined with CA 19-9 as a Biomarker of Intrahepatic Cholangiocarcinoma
| CANCERS |
2010 | Signet ring cell carcinoma of the extrahepatic bile duct
| GUT AND LIVER |
2020 | Single-center risk factor analysis for FOLFIRINOX associated febrile neutropenia in patients with pancreatic cancer | CANCER CHEMOTHERAPY AND PHARMACOLOGY |
2019 | Skeletal Muscle Mass Predicts Poor Prognosis in Patients with Advanced Pancreatic Cancer Undergoing Second-Line FOLFIRINOX Chemotherapy | NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL |
2016 | Statin Use and Its Impact on Survival in Pancreatic Cancer Patients Cancer Patients
| MEDICINE |
2006 | The clinical usefulness of 18-fluorodeoxyglucose positron emission tomography in the differential diagnosis, staging, and response evaluation after concurrent chemoradiotherapy for pancreatic cancer | JOURNAL OF CLINICAL GASTROENTEROLOGY |
2006 | The clinicopathologic significance of the expression of vascular endothelial growth factor-C in intrahepatic cholangiocarcinoma | AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS |
2005 | The differences in immune cells engaged in cell mediated immunity around chemotherapy of far advanced pancreatic cancer
| Thesis |
2014 | The Efficacy of Endoscopic Palliation of Obstructive Jaundice in Hepatocellular Carcinoma
| YONSEI MEDICAL JOURNAL |
2023 | The Expression of Programmed Death-Ligand 1 on Immune Cells Is Related to a Better Prognosis in Biliary Tract Cancer
| GUT AND LIVER |